世界の院内感染（HAI）診断市場 2021：企業別、地域別、種類・用途別

• 英文タイトル：Global Hospital Acquired Infections (HAI) Diagnostics Market 2021 by Company, Regions, Type and Application, Forecast to 2026

• レポートコード：GIR-107A12347 • 出版社/出版日：GlobalInfoResearch / 2021年7月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、75ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥515,040 (USD3,480)	▷ お問い合わせ
Multi User	￥772,560 (USD5,220)	▷ お問い合わせ
Corporate User	￥1,030,080 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

当調査資料では、院内感染（HAI）診断のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。院内感染（HAI）診断の種類別市場規模（分子診断検査、その他体外診断検査）、用途別市場規模（菌血症（BSI）、尿路感染症（UTI）、手術部位感染症（SSI）、肺炎、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・院内感染（HAI）診断の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：BioMérieux、Abbott Laboratories、Roche AG、Siemens Healthcare ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：分子診断検査、その他体外診断検査 ・用途別分析2016年-2026年：菌血症（BSI）、尿路感染症（UTI）、手術部位感染症（SSI）、肺炎、その他 ・院内感染（HAI）診断の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・院内感染（HAI）診断のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・院内感染（HAI）診断のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・院内感染（HAI）診断の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・院内感染（HAI）診断の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論

The Hospital Acquired Infections (HAI) Diagnostics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Hospital Acquired Infections (HAI) Diagnostics size is estimated to be USD 4021.5 million in 2026 from USD 3428.4 million in 2020, with a change XX% between 2020 and 2021. The global Hospital Acquired Infections (HAI) Diagnostics market size is expected to grow at a CAGR of 4.1% for the next five years.

Market segmentation
Hospital Acquired Infections (HAI) Diagnostics market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
Molecular Diagnostics Tests
Other In-vitro Diagnostic Tests

Market segment by Application, can be divided into
Bloodstream Infections (BSI)
Urinary Tract Infections (UTI)
Surgical Site Infections (SSI)
Pneumonia
Others

Market segment by players, this report covers
BioMérieux
Abbott Laboratories
Roche AG
Siemens Healthcare

Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Hospital Acquired Infections (HAI) Diagnostics product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Hospital Acquired Infections (HAI) Diagnostics, with revenue, gross margin and global market share of Hospital Acquired Infections (HAI) Diagnostics from 2019 to 2021.
Chapter 3, the Hospital Acquired Infections (HAI) Diagnostics competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by type and application, with revenue and growth rate by type, application, from 2016 to 2026.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2016 to 2021.and Hospital Acquired Infections (HAI) Diagnostics market forecast, by regions, type and application, with revenue, from 2021 to 2026.
Chapter 11 and 12, to describe Hospital Acquired Infections (HAI) Diagnostics research findings and conclusion, appendix and data source.

レポート目次

---

1 Market Overview
1.1 Product Overview and Scope of Hospital Acquired Infections (HAI) Diagnostics
1.2 Classification of Hospital Acquired Infections (HAI) Diagnostics by Type
1.2.1 Overview: Global Hospital Acquired Infections (HAI) Diagnostics Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Hospital Acquired Infections (HAI) Diagnostics Revenue Market Share by Type in 2020
1.2.3 Molecular Diagnostics Tests
1.2.4 Other In-vitro Diagnostic Tests
1.3 Global Hospital Acquired Infections (HAI) Diagnostics Market by Application
1.3.1 Overview: Global Hospital Acquired Infections (HAI) Diagnostics Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Bloodstream Infections (BSI)
1.3.3 Urinary Tract Infections (UTI)
1.3.4 Surgical Site Infections (SSI)
1.3.5 Pneumonia
1.3.6 Others
1.4 Global Hospital Acquired Infections (HAI) Diagnostics Market Size & Forecast
1.5 Global Hospital Acquired Infections (HAI) Diagnostics Market Size and Forecast by Region
1.5.1 Global Hospital Acquired Infections (HAI) Diagnostics Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Hospital Acquired Infections (HAI) Diagnostics Market Size by Region, (2016-2021)
1.5.3 North America Hospital Acquired Infections (HAI) Diagnostics Market Size and Prospect (2016-2026)
1.5.4 Europe Hospital Acquired Infections (HAI) Diagnostics Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Hospital Acquired Infections (HAI) Diagnostics Market Size and Prospect (2016-2026)
1.5.6 South America Hospital Acquired Infections (HAI) Diagnostics Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Hospital Acquired Infections (HAI) Diagnostics Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Hospital Acquired Infections (HAI) Diagnostics Market Drivers
1.6.2 Hospital Acquired Infections (HAI) Diagnostics Market Restraints
1.6.3 Hospital Acquired Infections (HAI) Diagnostics Trends Analysis
2 Company Profiles
2.1 BioMérieux
2.1.1 BioMérieux Details
2.1.2 BioMérieux Major Business
2.1.3 BioMérieux Hospital Acquired Infections (HAI) Diagnostics Product and Solutions
2.1.4 BioMérieux Hospital Acquired Infections (HAI) Diagnostics Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 BioMérieux Recent Developments and Future Plans
2.2 Abbott Laboratories
2.2.1 Abbott Laboratories Details
2.2.2 Abbott Laboratories Major Business
2.2.3 Abbott Laboratories Hospital Acquired Infections (HAI) Diagnostics Product and Solutions
2.2.4 Abbott Laboratories Hospital Acquired Infections (HAI) Diagnostics Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 Abbott Laboratories Recent Developments and Future Plans
2.3 Roche AG
2.3.1 Roche AG Details
2.3.2 Roche AG Major Business
2.3.3 Roche AG Hospital Acquired Infections (HAI) Diagnostics Product and Solutions
2.3.4 Roche AG Hospital Acquired Infections (HAI) Diagnostics Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 Roche AG Recent Developments and Future Plans
2.4 Siemens Healthcare
2.4.1 Siemens Healthcare Details
2.4.2 Siemens Healthcare Major Business
2.4.3 Siemens Healthcare Hospital Acquired Infections (HAI) Diagnostics Product and Solutions
2.4.4 Siemens Healthcare Hospital Acquired Infections (HAI) Diagnostics Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 Siemens Healthcare Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Hospital Acquired Infections (HAI) Diagnostics Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 3 Hospital Acquired Infections (HAI) Diagnostics Players Market Share
3.2.2 Top 10 Hospital Acquired Infections (HAI) Diagnostics Players Market Share
3.2.3 Market Competition Trend
3.3 Hospital Acquired Infections (HAI) Diagnostics Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Hospital Acquired Infections (HAI) Diagnostics Revenue and Market Share by Type (2016-2021)
4.2 Global Hospital Acquired Infections (HAI) Diagnostics Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Hospital Acquired Infections (HAI) Diagnostics Revenue Market Share by Application (2016-2021)
5.2 Hospital Acquired Infections (HAI) Diagnostics Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Hospital Acquired Infections (HAI) Diagnostics Revenue by Type (2016-2026)
6.2 North America Hospital Acquired Infections (HAI) Diagnostics Revenue by Application (2016-2026)
6.3 North America Hospital Acquired Infections (HAI) Diagnostics Market Size by Country
6.3.1 North America Hospital Acquired Infections (HAI) Diagnostics Revenue by Country (2016-2026)
6.3.2 United States Hospital Acquired Infections (HAI) Diagnostics Market Size and Forecast (2016-2026)
6.3.3 Canada Hospital Acquired Infections (HAI) Diagnostics Market Size and Forecast (2016-2026)
6.3.4 Mexico Hospital Acquired Infections (HAI) Diagnostics Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Hospital Acquired Infections (HAI) Diagnostics Revenue by Type (2016-2026)
7.2 Europe Hospital Acquired Infections (HAI) Diagnostics Revenue by Application (2016-2026)
7.3 Europe Hospital Acquired Infections (HAI) Diagnostics Market Size by Country
7.3.1 Europe Hospital Acquired Infections (HAI) Diagnostics Revenue by Country (2016-2026)
7.3.2 Germany Hospital Acquired Infections (HAI) Diagnostics Market Size and Forecast (2016-2026)
7.3.3 France Hospital Acquired Infections (HAI) Diagnostics Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Hospital Acquired Infections (HAI) Diagnostics Market Size and Forecast (2016-2026)
7.3.5 Russia Hospital Acquired Infections (HAI) Diagnostics Market Size and Forecast (2016-2026)
7.3.6 Italy Hospital Acquired Infections (HAI) Diagnostics Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Hospital Acquired Infections (HAI) Diagnostics Revenue by Type (2016-2026)
8.2 Asia-Pacific Hospital Acquired Infections (HAI) Diagnostics Revenue by Application (2016-2026)
8.3 Asia-Pacific Hospital Acquired Infections (HAI) Diagnostics Market Size by Region
8.3.1 Asia-Pacific Hospital Acquired Infections (HAI) Diagnostics Revenue by Region (2016-2026)
8.3.2 China Hospital Acquired Infections (HAI) Diagnostics Market Size and Forecast (2016-2026)
8.3.3 Japan Hospital Acquired Infections (HAI) Diagnostics Market Size and Forecast (2016-2026)
8.3.4 South Korea Hospital Acquired Infections (HAI) Diagnostics Market Size and Forecast (2016-2026)
8.3.5 India Hospital Acquired Infections (HAI) Diagnostics Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Hospital Acquired Infections (HAI) Diagnostics Market Size and Forecast (2016-2026)
8.3.7 Australia Hospital Acquired Infections (HAI) Diagnostics Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Hospital Acquired Infections (HAI) Diagnostics Revenue by Type (2016-2026)
9.2 South America Hospital Acquired Infections (HAI) Diagnostics Revenue by Application (2016-2026)
9.3 South America Hospital Acquired Infections (HAI) Diagnostics Market Size by Country
9.3.1 South America Hospital Acquired Infections (HAI) Diagnostics Revenue by Country (2016-2026)
9.3.2 Brazil Hospital Acquired Infections (HAI) Diagnostics Market Size and Forecast (2016-2026)
9.3.3 Argentina Hospital Acquired Infections (HAI) Diagnostics Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Hospital Acquired Infections (HAI) Diagnostics Revenue by Type (2016-2026)
10.2 Middle East & Africa Hospital Acquired Infections (HAI) Diagnostics Revenue by Application (2016-2026)
10.3 Middle East & Africa Hospital Acquired Infections (HAI) Diagnostics Market Size by Country
10.3.1 Middle East & Africa Hospital Acquired Infections (HAI) Diagnostics Revenue by Country (2016-2026)
10.3.2 Turkey Hospital Acquired Infections (HAI) Diagnostics Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Hospital Acquired Infections (HAI) Diagnostics Market Size and Forecast (2016-2026)
10.3.4 UAE Hospital Acquired Infections (HAI) Diagnostics Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer

List of Tables
Table 1. Global Hospital Acquired Infections (HAI) Diagnostics Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Hospital Acquired Infections (HAI) Diagnostics Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Hospital Acquired Infections (HAI) Diagnostics Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Hospital Acquired Infections (HAI) Diagnostics Revenue (USD Million) by Region (2016-2021)
Table 5. Global Hospital Acquired Infections (HAI) Diagnostics Revenue Market Share by Region (2021-2026)
Table 6. BioMérieux Corporate Information, Head Office, and Major Competitors
Table 7. BioMérieux Major Business
Table 8. BioMérieux Hospital Acquired Infections (HAI) Diagnostics Product and Solutions
Table 9. BioMérieux Hospital Acquired Infections (HAI) Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. Abbott Laboratories Corporate Information, Head Office, and Major Competitors
Table 11. Abbott Laboratories Major Business
Table 12. Abbott Laboratories Hospital Acquired Infections (HAI) Diagnostics Product and Solutions
Table 13. Abbott Laboratories Hospital Acquired Infections (HAI) Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. Roche AG Corporate Information, Head Office, and Major Competitors
Table 15. Roche AG Major Business
Table 16. Roche AG Hospital Acquired Infections (HAI) Diagnostics Product and Solutions
Table 17. Roche AG Hospital Acquired Infections (HAI) Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. Siemens Healthcare Corporate Information, Head Office, and Major Competitors
Table 19. Siemens Healthcare Major Business
Table 20. Siemens Healthcare Hospital Acquired Infections (HAI) Diagnostics Product and Solutions
Table 21. Siemens Healthcare Hospital Acquired Infections (HAI) Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. Global Hospital Acquired Infections (HAI) Diagnostics Revenue (USD Million) by Players (2019-2021)
Table 23. Global Hospital Acquired Infections (HAI) Diagnostics Revenue Share by Players (2019-2021)
Table 24. Breakdown of Hospital Acquired Infections (HAI) Diagnostics by Company Type (Tier 1, Tier 2 and Tier 3)
Table 25. Hospital Acquired Infections (HAI) Diagnostics Players Head Office, Products and Services Provided
Table 26. Hospital Acquired Infections (HAI) Diagnostics Mergers & Acquisitions in the Past Five Years
Table 27. Hospital Acquired Infections (HAI) Diagnostics New Entrants and Expansion Plans
Table 28. Global Hospital Acquired Infections (HAI) Diagnostics Revenue (USD Million) by Type (2016-2021)
Table 29. Global Hospital Acquired Infections (HAI) Diagnostics Revenue Share by Type (2016-2021)
Table 30. Global Hospital Acquired Infections (HAI) Diagnostics Revenue Forecast by Type (2021-2026)
Table 31. Global Hospital Acquired Infections (HAI) Diagnostics Revenue by Application (2016-2021)
Table 32. Global Hospital Acquired Infections (HAI) Diagnostics Revenue Forecast by Application (2021-2026)
Table 33. North America Hospital Acquired Infections (HAI) Diagnostics Revenue by Type (2016-2021) & (USD Million)
Table 34. North America Hospital Acquired Infections (HAI) Diagnostics Revenue by Type (2021-2026) & (USD Million)
Table 35. North America Hospital Acquired Infections (HAI) Diagnostics Revenue by Application (2016-2021) & (USD Million)
Table 36. North America Hospital Acquired Infections (HAI) Diagnostics Revenue by Application (2021-2026) & (USD Million)
Table 37. North America Hospital Acquired Infections (HAI) Diagnostics Revenue by Country (2016-2021) & (USD Million)
Table 38. North America Hospital Acquired Infections (HAI) Diagnostics Revenue by Country (2021-2026) & (USD Million)
Table 39. Europe Hospital Acquired Infections (HAI) Diagnostics Revenue by Type (2016-2021) & (USD Million)
Table 40. Europe Hospital Acquired Infections (HAI) Diagnostics Revenue by Type (2021-2026) & (USD Million)
Table 41. Europe Hospital Acquired Infections (HAI) Diagnostics Revenue by Application (2016-2021) & (USD Million)
Table 42. Europe Hospital Acquired Infections (HAI) Diagnostics Revenue by Application (2021-2026) & (USD Million)
Table 43. Europe Hospital Acquired Infections (HAI) Diagnostics Revenue by Country (2016-2021) & (USD Million)
Table 44. Europe Hospital Acquired Infections (HAI) Diagnostics Revenue by Country (2021-2026) & (USD Million)
Table 45. Asia-Pacific Hospital Acquired Infections (HAI) Diagnostics Revenue by Type (2016-2021) & (USD Million)
Table 46. Asia-Pacific Hospital Acquired Infections (HAI) Diagnostics Revenue by Type (2021-2026) & (USD Million)
Table 47. Asia-Pacific Hospital Acquired Infections (HAI) Diagnostics Revenue by Application (2016-2021) & (USD Million)
Table 48. Asia-Pacific Hospital Acquired Infections (HAI) Diagnostics Revenue by Application (2021-2026) & (USD Million)
Table 49. Asia-Pacific Hospital Acquired Infections (HAI) Diagnostics Revenue by Region (2016-2021) & (USD Million)
Table 50. Asia-Pacific Hospital Acquired Infections (HAI) Diagnostics Revenue by Region (2021-2026) & (USD Million)
Table 51. South America Hospital Acquired Infections (HAI) Diagnostics Revenue by Type (2016-2021) & (USD Million)
Table 52. South America Hospital Acquired Infections (HAI) Diagnostics Revenue by Type (2021-2026) & (USD Million)
Table 53. South America Hospital Acquired Infections (HAI) Diagnostics Revenue by Application (2016-2021) & (USD Million)
Table 54. South America Hospital Acquired Infections (HAI) Diagnostics Revenue by Application (2021-2026) & (USD Million)
Table 55. South America Hospital Acquired Infections (HAI) Diagnostics Revenue by Country (2016-2021) & (USD Million)
Table 56. South America Hospital Acquired Infections (HAI) Diagnostics Revenue by Country (2021-2026) & (USD Million)
Table 57. Middle East & Africa Hospital Acquired Infections (HAI) Diagnostics Revenue by Type (2016-2021) & (USD Million)
Table 58. Middle East & Africa Hospital Acquired Infections (HAI) Diagnostics Revenue by Type (2021-2026) & (USD Million)
Table 59. Middle East & Africa Hospital Acquired Infections (HAI) Diagnostics Revenue by Application (2016-2021) & (USD Million)
Table 60. Middle East & Africa Hospital Acquired Infections (HAI) Diagnostics Revenue by Application (2021-2026) & (USD Million)
Table 61. Middle East & Africa Hospital Acquired Infections (HAI) Diagnostics Revenue by Country (2016-2021) & (USD Million)
Table 62. Middle East & Africa Hospital Acquired Infections (HAI) Diagnostics Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Hospital Acquired Infections (HAI) Diagnostics Picture
Figure 2. Global Hospital Acquired Infections (HAI) Diagnostics Revenue Market Share by Type in 2020
Figure 3. Molecular Diagnostics Tests
Figure 4. Other In-vitro Diagnostic Tests
Figure 5. Hospital Acquired Infections (HAI) Diagnostics Revenue Market Share by Application in 2020
Figure 6. Bloodstream Infections (BSI) Picture
Figure 7. Urinary Tract Infections (UTI) Picture
Figure 8. Surgical Site Infections (SSI) Picture
Figure 9. Pneumonia Picture
Figure 10. Others Picture
Figure 11. Global Hospital Acquired Infections (HAI) Diagnostics Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 12. Global Hospital Acquired Infections (HAI) Diagnostics Revenue and Forecast (2016-2026) & (USD Million)
Figure 13. Global Hospital Acquired Infections (HAI) Diagnostics Revenue Market Share by Region (2016-2026)
Figure 14. Global Hospital Acquired Infections (HAI) Diagnostics Revenue Market Share by Region in 2020
Figure 15. North America Hospital Acquired Infections (HAI) Diagnostics Revenue (USD Million) and Growth Rate (2016-2026)
Figure 16. Europe Hospital Acquired Infections (HAI) Diagnostics Revenue (USD Million) and Growth Rate (2016-2026)
Figure 17. Asia-Pacific Hospital Acquired Infections (HAI) Diagnostics Revenue (USD Million) and Growth Rate (2016-2026)
Figure 18. South America Hospital Acquired Infections (HAI) Diagnostics Revenue (USD Million) and Growth Rate (2016-2026)
Figure 19. Middle East and Africa Hospital Acquired Infections (HAI) Diagnostics Revenue (USD Million) and Growth Rate (2016-2026)
Figure 20. Hospital Acquired Infections (HAI) Diagnostics Market Drivers
Figure 21. Hospital Acquired Infections (HAI) Diagnostics Market Restraints
Figure 22. Hospital Acquired Infections (HAI) Diagnostics Market Trends
Figure 23. BioMérieux Recent Developments and Future Plans
Figure 24. Abbott Laboratories Recent Developments and Future Plans
Figure 25. Roche AG Recent Developments and Future Plans
Figure 26. Siemens Healthcare Recent Developments and Future Plans
Figure 27. Global Hospital Acquired Infections (HAI) Diagnostics Revenue Share by Players in 2020
Figure 28. Hospital Acquired Infections (HAI) Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 29. Global Top 3 Players Hospital Acquired Infections (HAI) Diagnostics Revenue Market Share in 2020
Figure 30. Global Top 10 Players Hospital Acquired Infections (HAI) Diagnostics Revenue Market Share in 2020
Figure 31. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 32. Global Hospital Acquired Infections (HAI) Diagnostics Revenue Share by Type in 2020
Figure 33. Global Hospital Acquired Infections (HAI) Diagnostics Market Share Forecast by Type (2021-2026)
Figure 34. Global Hospital Acquired Infections (HAI) Diagnostics Revenue Share by Application in 2020
Figure 35. Global Hospital Acquired Infections (HAI) Diagnostics Market Share Forecast by Application (2021-2026)
Figure 36. North America Hospital Acquired Infections (HAI) Diagnostics Sales Market Share by Type (2016-2026)
Figure 37. North America Hospital Acquired Infections (HAI) Diagnostics Sales Market Share by Application (2016-2026)
Figure 38. North America Hospital Acquired Infections (HAI) Diagnostics Revenue Market Share by Country (2016-2026)
Figure 39. United States Hospital Acquired Infections (HAI) Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 40. Canada Hospital Acquired Infections (HAI) Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 41. Mexico Hospital Acquired Infections (HAI) Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 42. Europe Hospital Acquired Infections (HAI) Diagnostics Sales Market Share by Type (2016-2026)
Figure 43. Europe Hospital Acquired Infections (HAI) Diagnostics Sales Market Share by Application (2016-2026)
Figure 44. Europe Hospital Acquired Infections (HAI) Diagnostics Revenue Market Share by Country (2016-2026)
Figure 45. Germany Hospital Acquired Infections (HAI) Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 46. France Hospital Acquired Infections (HAI) Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 47. United Kingdom Hospital Acquired Infections (HAI) Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 48. Russia Hospital Acquired Infections (HAI) Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 49. Italy Hospital Acquired Infections (HAI) Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 50. Asia-Pacific Hospital Acquired Infections (HAI) Diagnostics Sales Market Share by Type (2016-2026)
Figure 51. Asia-Pacific Hospital Acquired Infections (HAI) Diagnostics Sales Market Share by Application (2016-2026)
Figure 52. Asia-Pacific Hospital Acquired Infections (HAI) Diagnostics Revenue Market Share by Region (2016-2026)
Figure 53. China Hospital Acquired Infections (HAI) Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. Japan Hospital Acquired Infections (HAI) Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. South Korea Hospital Acquired Infections (HAI) Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. India Hospital Acquired Infections (HAI) Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. Southeast Asia Hospital Acquired Infections (HAI) Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. Australia Hospital Acquired Infections (HAI) Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. South America Hospital Acquired Infections (HAI) Diagnostics Sales Market Share by Type (2016-2026)
Figure 60. South America Hospital Acquired Infections (HAI) Diagnostics Sales Market Share by Application (2016-2026)
Figure 61. South America Hospital Acquired Infections (HAI) Diagnostics Revenue Market Share by Country (2016-2026)
Figure 62. Brazil Hospital Acquired Infections (HAI) Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. Argentina Hospital Acquired Infections (HAI) Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. Middle East and Africa Hospital Acquired Infections (HAI) Diagnostics Sales Market Share by Type (2016-2026)
Figure 65. Middle East and Africa Hospital Acquired Infections (HAI) Diagnostics Sales Market Share by Application (2016-2026)
Figure 66. Middle East and Africa Hospital Acquired Infections (HAI) Diagnostics Revenue Market Share by Country (2016-2026)
Figure 67. Turkey Hospital Acquired Infections (HAI) Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 68. Saudi Arabia Hospital Acquired Infections (HAI) Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 69. UAE Hospital Acquired Infections (HAI) Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 70. Methodology
Figure 71. Research Process and Data Source

---